CN104352486B - 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine - Google Patents

5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine Download PDF

Info

Publication number
CN104352486B
CN104352486B CN201410450601.2A CN201410450601A CN104352486B CN 104352486 B CN104352486 B CN 104352486B CN 201410450601 A CN201410450601 A CN 201410450601A CN 104352486 B CN104352486 B CN 104352486B
Authority
CN
China
Prior art keywords
hydroxymethyl furfural
emptying
hmf
stomach
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410450601.2A
Other languages
Chinese (zh)
Other versions
CN104352486A (en
Inventor
杨迺嘉
刘建华
高玉琼
霍昕
王仕梅
徐康东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guizhou Biotechnology Research And Development Base Co ltd
Original Assignee
GUIZHOU PROV BIOLOGICAL TECHN RESEARCH & DEVELOPMENT BASE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUIZHOU PROV BIOLOGICAL TECHN RESEARCH & DEVELOPMENT BASE filed Critical GUIZHOU PROV BIOLOGICAL TECHN RESEARCH & DEVELOPMENT BASE
Priority to CN201410450601.2A priority Critical patent/CN104352486B/en
Publication of CN104352486A publication Critical patent/CN104352486A/en
Application granted granted Critical
Publication of CN104352486B publication Critical patent/CN104352486B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of 5 Hydroxymethylfurfural purposes in preparing stomach motility enhancing medicine, belong to pharmaceutical technology field, selecting Mouse Stomach emptying experiment is pharmacological basis, emptying test method: utilize endoscope clinically or observe the situation that certain material disappears at gastric, and judging the air emptying function of stomach;Experimentation then according to injection and the retention amount of gastric content, is directly measured;By pharmacological evaluation, this research, with methyl orange as index, proves that 5 Hydroxymethylfurfural have the effect of rush gastric emptying.

Description

5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine
Technical field
The invention belongs to pharmaceutical technology field, relate in particular to a kind of 5 hydroxymethyl furfural and preparing stomach motility enhancing medicine In application.
Background technology
5 hydroxymethyl furfural is the aldehydes that the monosaccharide compounds such as glucose produce in the dehydration of the condition such as high temperature or weak acid Compound, typically after concocting or heating, content can raise, and this compound all contains time composition in most Chinese medicines.In the past to 5- The research of Hydroxymethylfurfural thinks there is the control of content in medicine and food, but nearest research finds that it has the newest medicine Reason effect (Fu Ziqin, Wang Mingyan, Cai precious prosperous .5-Hydroxymethylfurfural 5-HMF the Research Status [J] China in Chinese medicine Chinese medicine academic periodical, 2008,26(3) 508-510).:
(1) resist myocardial ischemia
In recent years, finding in the studying of compound prescription of Chinese herbs, 5 hydroxymethyl furfural has certain function of resisting myocardial ischemia.To raw arteries and veins The chemical composition dissipated is studied, and from its dividual decoction, one new component of isolated, is accredited as through UV, IR, MS and H NMR spectroscopy 5-HMF .Meanwhile, research finds, single medicinal material without 5-HMF, can produce a small amount of 5-before decoction after single Fructus Schisandrae Chinensis decocting HMF, does not finds Radix Ginseng, Radix Ophiopogonis 5-HMF in decocting liquid, and SHENGMAI SAN side entirely and Radix Ophiopogonis and 5-HM in the decocting liquid of Fructus Schisandrae Chinensis compatibility The content of F significantly increases, thus it is speculated that 5-HMF generates may be relevant with Fructus Schisandrae Chinensis acidity, and its content is mainly affected by Radix Ophiopogonis.Enter One step carries out finding after pharmacodynamic study, full side close the drug effect decocted be substantially better than the party single decoct combination of two compatibility or tripartite single The drug effect of mixing after Jianing, thus it is speculated that this result may be relevant with 5-HMF contained therein and content thereof.Separating obtained 5-HMF are entered Row Pharmacodynamic is tested, and research shows, 5-HMF can reduce LDA content in myocardial ischemia mice serum, reduces myocardial ischemia little MDA content in Mus cardiac muscular tissue, after pointing out SHENGMAI SAN the most just to decoct, the change of chemical composition is conducive to its function of resisting myocardial ischemia, Its generation is favourable to compound recipe entirety curative effect, is one of material base of resisting myocardial ischemia of SHENGMAI SAN.
(2) antioxidation
The 5-HMF that former three medical materials of isolation identification do not have from SHENGMAI SAN decoct in recent years, it was demonstrated that 5-HMF is except having the anti-heart Outside myocardial ischemia effect, also there is good antioxidation.Meanwhile, it has been reported that containing 5-HMF in Maotai, have stronger resisting Oxidisability, is of value to oral health, and has function of resisting myocardial ischemia equally.
(3) Ca2+Antagonistic activity
Research finds, can generate 5-HMF, have Ca after the processed process of preparing Chinese medicine of sucrose contained in prunus mume (sieb.) sieb.et zucc. fruit (such as Fructus Mume)2+Short of money Resistant activity, the activity that the guinea pig colonic belt having stronger antagonism to be caused by potassium ion shrinks.Meanwhile, Fructus Mume has antiallergic work With, its antiallergic mechanism is probably the result of the anaphylactogen in the free antibodies that nonspecific stimulation produces and in intrusive body, has People thinks that this mechanism of action may be relevant with 5-HMF contained therein.
(4) hemorheology is improved
Research finds, Radix Rehmanniae generates 5 HMF during steaming, and extends with steaming time, 5-HMF content in Radix Rehmanniae Preparata Increasing, after concocting ripe Radix Rehmanniae, its content increases about 20 times.And pharmacodynamic experiment finds that Radix Rehmanniae Preparata can be red carefully by improvement The erythrocyte such as born of the same parents' deformability, RCA body formation are dynamic, and improve hemorheology by making fibrinolytic system function strengthen Learn, thus present blood promote effect, compared with Radix Rehmanniae Preparata, health product acts on more weak in this respect, this may with both contained by 5- The difference of HMF content is relevant.It addition, from the yellow Fructus Pruni originating in Japan isolated 5-HMF, confirm 5-equally by experiment HMF has certain effect in terms of improving hemorheology.
(5) glycyrrhizic acid metabolism is affected
It has been reported that, containing the composition such as glucose, sucrose, 5-HMF in Mel, these 3 kinds of composition rabbit respectively are administered orally to After medicine, observe it to glycyrrhizic acid in rabbit body and the impact of enoxolone metabolic condition.Result shows, 5-HMF can suppress Radix Glycyrrhizae Subacid is oxidized to 3-dehydrogenation enoxolone, increases enoxolone absorption in vivo, thus promotes glycyrrhizic acid and enoxolone Suppression tumor, antiinflammatory, the effect of reduction blood cholesterol.
(6) other
In recent years, people is had within 30 days, to cause rat with the perfusion of mitochondrial respiratory chain complex IV inhibitor sodium azide Micropump constant speed Neuronal energy dysbolismus and ability of learning and memory lower, thus study kidney-nourishing tcm drug Fructus Corni monomer component 5-HMF effect, Result shows, 5-HMF can cause neurocyte mitochondrial transmembrane potentials and decline by antagonism sodium azide, and can raise and turn AD patient's line The mitochondrial membrane potential of mitochondrial DNA fused cell.
Summary of the invention
A kind of 5 hydroxymethyl furfural that it is an object of the invention to provide purposes in preparing stomach motility enhancing medicine.
The present invention be select Mouse Stomach emptying experiment for pharmacological basis (emptying test method: utilize clinically endoscope or Observe the situation that certain material disappears at gastric, and judge the air emptying function of stomach;Experimentation is then according to the injection of gastric content And retention amount, directly measure (Xu Shuyun etc., 2006);This research is (king is supporting just etc., 2008) with methyl orange as index.Pass through Pharmacological evaluation proves that 5 hydroxymethyl furfural has the effect promoting gastric emptying
Detailed description of the invention
The present invention is with mice as laboratory animal, observes 5 hydroxymethyl furfural and the stomach motility enhancing effect of preparation thereof, specifically Test as follows:
1. instrument and material
1.1 instrument
AL-204 type electronic balance (Shanghai prunus mume (sieb.) sieb.et zucc. Teller-Tuo Li Instrument Ltd.)
TU-1810 ultraviolet-uisible spectrophotometer (Beijing Pu Xi all purpose instrument Co., Ltd)
SK250LH-ultrasonic cleaner (Shanghai Ke Dao Instrument Ltd.)
0412-1 table-type low-speed centrifuge (Shanghai Medical apparatus company limited operating theater instruments factory)
Material
Positive control drug motilium (Xian-Janssen Pharmaceutical Ltd., lot number 110316588)
5 hydroxymethyl furfural (Industrial Co., Ltd. of upper ingression section, lot number Q-00469)
5 hydroxymethyl furfural tablet, capsule, granule are to make by oneself by following example, and remaining is domestic reagent.
1.3. laboratory animal
Kunming kind SPF mice, is provided by Guiyang Medical College animal center, the laboratory animal quality certification number: SCSK(Guizhou Province) lot number: 2004-0001。
2. method and result
2.1 prepare for reagent: take 5 hydroxymethyl furfural 2g(200mg Han 5 hydroxymethyl furfural respectively), use distilled water 20mL Diluted for use;Separately take 5 hydroxymethyl furfural tablet 6g(200mg Han 5 hydroxymethyl furfural), 5 hydroxymethyl furfural capsule 6g(contains 5 hydroxymethyl furfural 200mg), it is suspended in 20mL distilled water standby;Take 5 hydroxymethyl furfural granule 100g(methylol bran Han 5- Aldehyde 200mg), it is suspended in 75mL distilled water standby with distilled water;
Prepared by 2.2 positive drug motilium water: take motilium tablet 2g(200mg Han motilium), add distilled water 20ml, fully After stirring and dissolving standby.
Test sample content of dispersion:
5 hydroxymethyl furfural: 0.01g/ml
Motilium: 0.01 g/ml
5 hydroxymethyl furfural tablet: 0.01g/ml
5 hydroxymethyl furfural capsule: 0.01g/ml
5 hydroxymethyl furfural granule: 2.7mg/ml
The impact of 2.3 Mouse Stomach emptyings
Take mice 40, male and female half and half, body weight 18~22g, be randomly divided into 5-HFM tablet group, 5-HFM capsule group, 5- HFM group, positive motilium group, blank group.Blank group gavage gives normal saline, and other group gavages give corresponding medicine Thing solution, every mice is administered 0.1ml/10g, continuous gavage 4 days;Separately take every mice of 5-HFM granule group to be administered 0.325ml/10g, continuous gavage 4 days;After last is administered 1 hour, gavage 0.5% methyl orange solution 0.2ml/ every respectively, 30 After clock, mice cervical dislocation is put to death, and takes out complete stomach, rubs, drip appropriate 5% in the test tube equipped with 10ml normal saline NaHCO3 solution, adjusting solution ph is about 7, centrifugal 15 minutes, takes the supernatant, with ultraviolet-uisible spectrophotometer in wavelength Absorbance A value is surveyed at 463nm.Result see table 1-1,
The impact that Mouse Stomach is emptied by table 1-1 reactive compound
Sequence number Number of animals (only) Dosage (g/kg/d) Methyl orange absorbance A P value
5-HM 10 0.1 0.925** 0.00356**
Embodiment 1 10 0.1 0.924** 0.00539**
Embodiment 2 10 0.1 0.919** 0.00673**
Embodiment 3 10 0.1 0.927** 0.00481**
Motilium 10 0.1 0.936** 0.00334**
Blank 10 0.830 0
* P < 0.05, * * P < 0.01 is compared respectively with blank group
Proved by pharmacological evaluation, 5 hydroxymethyl furfural, 5 hydroxymethyl furfural tablet, 5 hydroxymethyl furfural capsule, 5- Hydroxymethylfurfural granule, motilium P value are respectively less than 0.01, illustrate that it has pole significant difference compared with blank group.
Effect to be reached, treatment time and administering mode are depended in metering;With the metering of motilium as reference, these Metering is usually adult's tablet oral every day, capsule 300-900mg, granule 5-15g, and unit dosage is 5 hydroxymethyl furfural 10-30mg。
Embodiment 1: there is the following composition tablet containing 5 hydroxymethyl furfural 10mg according to routine techniques preparation
5 hydroxymethyl furfural 10mg
Starch 36mg
Dextrin 30mg
Carboxymethylstach sodium 8mg
Magnesium stearate 53mg
Sodium carboxymethyl cellulose 53mg
Starch slurry 18% 110mg
Embodiment 2: there is the following composition capsule containing 5 hydroxymethyl furfural 10mg according to routine techniques preparation
5 hydroxymethyl furfural 10mg
Starch 135mg
Pulvis Talci 65mg
Carboxymethylstach sodium 45mg
Dibastic sodium phosphate 35mg
Magnesium stearate 10mg
Embodiment 3: there is the following composition granule containing 5 hydroxymethyl furfural 10mg according to routine techniques preparation
5 hydroxymethyl furfural 10mg
Dextrin 450m g
Sucrose 4540mg
The above, be only presently preferred embodiments of the present invention, and the present invention not makees any pro forma restriction, Any without departing from technical solution of the present invention content, any simply repaiied according to what above example made by the technical spirit of the present invention Change, equivalent variations and modification, all still fall within the range of technical solution of the present invention.

Claims (1)

1. a 5 hydroxymethyl furfural is as sole active composition purposes in preparing stomach motility enhancing medicine.
CN201410450601.2A 2014-09-05 2014-09-05 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine Active CN104352486B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410450601.2A CN104352486B (en) 2014-09-05 2014-09-05 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410450601.2A CN104352486B (en) 2014-09-05 2014-09-05 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine

Publications (2)

Publication Number Publication Date
CN104352486A CN104352486A (en) 2015-02-18
CN104352486B true CN104352486B (en) 2016-08-17

Family

ID=52519862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410450601.2A Active CN104352486B (en) 2014-09-05 2014-09-05 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine

Country Status (1)

Country Link
CN (1) CN104352486B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1286455C (en) * 2003-01-30 2006-11-29 普文英 Pharmaceutical use of 5-hydroxymethyl furfural

Also Published As

Publication number Publication date
CN104352486A (en) 2015-02-18

Similar Documents

Publication Publication Date Title
CN103585400B (en) Have and strengthen immunologic function and the compositions alleviating fatigue effect and preparation method thereof
CN112972547A (en) Traditional Chinese medicine composition for treating qi-blood deficiency syndrome and preparation method and application thereof
WO2010037256A1 (en) Composition for reducing blood fat and blood glucose
CN106214845A (en) A kind of pharmaceutical composition with health care and preparation method thereof
CN105663444A (en) Compound immunity-enhancing and aging-resisting agent and preparation method thereof
CN103860638B (en) Preparation method of sophora alopecuroide flavonoid composition and new medical application
CN101879268B (en) Method for preparing Chinese medicinal oral liquid for treating attention deficit hyperactivity disorder
CN104147345B (en) A kind of Chinese medicine composition for treating cardiovascular autonomic neuropathy
CN103191198A (en) Rhizoma corydalis extract as well as preparation method and use thereof
CN101890056A (en) Medicinal composition for enhancing immunologic function
CN104352486B (en) 5 hydroxymethyl furfural purposes in preparing stomach motility enhancing medicine
US9445624B2 (en) Anti-fatigue composition of plant material and preparation method, use and products thereof
CN104208303B (en) A kind of Chinese medicine preparation for treating hyperlipemia and preparation method thereof
CN103610051A (en) Food, healthcare food or medicine composition with lipid-lowering effect as well as preparation methods and applications thereof
CN104286844B (en) A kind of improve the food of immunity, health product or pharmaceutical composition
CN107041924A (en) It is a kind of prevent and treat diabetic nephropathy towards medicine compound extract and preparation method thereof
CN104162058A (en) Traditional Chinese medicine compound preparation for treating gout and preparation method thereof
CN102600281A (en) Traditional Chinese medicine composition for promoting digestion as well as preparation method and use
CN107693732B (en) Medicine composition for treating hypertensive nephropathy and preparation method thereof
CN101015574A (en) Preparing method of traditional Chinese medicine pills for treating hepatitis
CN103932184A (en) Traditional Chinese medicine combination
CN105055967B (en) A kind of complex health care product and preparation method with auxiliary hyperglycemic function
CN106928376A (en) The separation method of skunk bush polysaccharide and its application
Guan et al. Study on anti-tumor effect of Solanum lyratum Thunb. extract in S180 tumor-bearing mice
CN105285623B (en) Health-care beverage with function of improving immunity and making method of health-care beverage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 551400 High-tech Industrial Planning Zone, Qingzhen City, Guiyang City, Guizhou Province (No. 109, Lishan Road)

Patentee after: Guizhou Biotechnology Research and Development Base Co.,Ltd.

Address before: No. 17, Nanchong Lane, Jiefang West Road, Guiyang City, Guizhou Province, 550004

Patentee before: GUIZHOU BIOTECHNOLOGY RESEARCH AND DEVELOPMENT BASE